Goldman Sachs’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $101K | Buy |
|
|||||
|
2024
Q1 | $47K | Sell |
|
|||||
|
2023
Q4 | $156K | Buy |
|
|||||
|
2023
Q3 | $227K | Sell |
|
|||||
|
2023
Q2 | $809K | Sell |
|
|||||
|
2023
Q1 | $1.49M | Buy |
|
|||||
|
2022
Q4 | $3.17M | Buy |
|
|||||
|
2022
Q3 | $2.49M | Buy |
|
|||||
|
2022
Q2 | $1.33M | Buy |
|
|||||
|
2022
Q1 | $1.55M | Buy |
|
|||||
|
2021
Q4 | $1.53M | Sell |
|
|||||
|
2021
Q3 | $4.74M | Sell |
|
|||||
|
2021
Q2 | $5.41M | Sell |
|
|||||
|
2021
Q1 | $9.62M | Sell |
|
|||||
|
2020
Q4 | $9.09M | Sell |
|
|||||
|
2020
Q3 | $7.83M | Buy |
|
|||||
|
2020
Q2 | $5.53M | Buy |
|
|||||
|
2020
Q1 | $2.8M | Sell |
|
|||||
|
2019
Q4 | $4.07M | Sell |
|
|||||
|
2019
Q3 | $5.5M | Buy |
|
|||||
|
2019
Q2 | $1.93M | Buy |
|
|||||
|
2019
Q1 | $1.12M | Sell |
|
|||||
|
2018
Q4 | $1.23M | Sell |
|
|||||
|
2018
Q3 | $3.82M | Sell |
|
|||||
|
2018
Q2 | $4.06M | Buy |
|
|||||
|
2018
Q1 | $372K | Sell |
|
|||||
|
2017
Q4 | $964K | Buy |
|
|||||
|
2017
Q3 | $446K | Sell |
|
|||||
|
2017
Q2 | $1.3M | Buy |
|
|||||
|
2017
Q1 | $216K | Sell |
|
|||||
|
2016
Q4 | $282K | Buy |
|
|||||
|
2016
Q3 | $231K | Sell |
|
|||||
|
2016
Q2 | $135K | Buy |
|
|||||
|
2016
Q1 | $79K | Buy |
|